ID HMT-3522 T4-2 AC CVCL_2501 SY T4-2; T4; HMT-3522/mt-1; mt-1; HMT-3522/massive tumor-1 DR BTO; BTO_0006210 DR ArrayExpress; E-TABM-244 DR cancercelllines; CVCL_2501 DR ECACC; 98102212 DR GEO; GSM1172999 DR GEO; GSM1219379 DR GEO; GSM1219380 DR GEO; GSM1219381 DR GEO; GSM1219382 DR GEO; GSM1219383 DR GEO; GSM1219384 DR GEO; GSM1219385 DR GEO; GSM1219386 DR GEO; GSM1219387 DR GEO; GSM1219388 DR GEO; GSM1219389 DR GEO; GSM1219390 DR GEO; GSM1219391 DR GEO; GSM1219392 DR GEO; GSM1219393 DR GEO; GSM1219394 DR GEO; GSM1219395 DR GEO; GSM1219396 DR GEO; GSM1219397 DR LINCS_HMS; 51123 DR PharmacoDB; T4_1558_2019 DR Wikidata; Q54889970 RX PubMed=8616848; RX PubMed=18316601; RX PubMed=18516279; RX PubMed=24176112; WW Info; Synapse; JWGray panel; https://www.synapse.org/#!Synapse:syn2346643/wiki/62255 CC Part of: JWGray breast cancer cell line panel. CC Population: Caucasian. CC Doubling time: 32.94 hours (JWGray panel). CC Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.His179Asn (c.535C>A); ClinVar=VCV000376609; Zygosity=Unspecified (from parent cell line). CC Omics: Genomics; Whole exome sequencing. CC Omics: Transcriptomics; Microarray. CC Omics: Variations; SNP array analysis. CC Donor information: Established from a nontumorigenic fibrocystic breast lesion (from parent cell line). CC Derived from site: In situ; Breast, epithelium; UBERON=UBERON_0008367. CC Cell type: Epithelial cell of mammary gland; CL=CL_0002327. ST Source(s): ECACC=98102212 ST Amelogenin: X ST CSF1PO: 11,12 ST D13S317: 11 ST D16S539: 11,13 ST D5S818: 9,11 ST D7S820: 8,9 ST TH01: 9,9.3 ST TPOX: 8,11 ST vWA: 14,17 OX NCBI_TaxID=9606; ! Homo sapiens (Human) HI CVCL_2500 ! HMT-3522 S2 SX Female AG 50Y CA Spontaneously immortalized cell line DT Created: 04-04-12; Last updated: 10-04-25; Version: 22 // RX PubMed=18516279; DOI=10.1016/j.molonc.2007.02.004; PMCID=PMC2391005; RA Kenny, Paraic A. RA Lee, Genee Y. RA Myers, Connie A. RA Neve, Richard M. RA Semeiks, Jeremy R. RA Spellman, Paul T. RA Lorenz, Kristina RA Lee, Eva H. RA Barcellos-Hoff, Mary Helen RA Petersen, Ole William RA Gray, Joe W. RA Bissell, Mina J. RT "The morphologies of breast cancer cell lines in three-dimensional RT assays correlate with their profiles of gene expression."; RL Mol. Oncol. 1:84-96(2007). // RX PubMed=8616848; RA Briand, Per RA Nielsen, Kirsten Vang RA Madsen, Mogens W. RA Petersen, Ole William RT "Trisomy 7p and malignant transformation of human breast epithelial RT cells following epidermal growth factor withdrawal."; RL Cancer Res. 56:2039-2044(1996). // RX PubMed=24176112; DOI=10.1186/gb-2013-14-10-r110; PMCID=PMC3937590; RA Daemen, Anneleen RA Griffith, Obi L. RA Heiser, Laura M. RA Wang, Nicholas J. RA Enache, Oana M. RA Sanborn, Zachary J. RA Pepin, Francois RA Durinck, Steffen RA Korkola, James E. RA Griffith, Malachi RA Hur, Joe S. RA Huh, Nam RA Chung, Jongsuk RA Cope, Leslie RA Fackler, Mary Jo RA Umbricht, Christopher Benedict RA Sukumar, Saraswati RA Seth, Pankaj RA Sukhatme, Vikas P. RA Jakkula, Lakshmi R. RA Lu, Yi-Ling RA Mills, Gordon B. RA Cho, Raymond J. RA Collisson, Eric A. RA van 't Veer, Laura J. RA Spellman, Paul T. RA Gray, Joe W. RT "Modeling precision treatment of breast cancer."; RL Genome Biol. 14:R110.1-R110.14(2013). // RX PubMed=18316601; DOI=10.1158/0008-5472.CAN-07-2225; PMCID=PMC2662716; RA Rizki, Aylin RA Weaver, Valerie Marie RA Lee, Sun-Young RA Rozenberg, Gabriela I. RA Chin, Koei RA Myers, Connie A. RA Bascom, Jamie L. RA Mott, Joni D. RA Semeiks, Jeremy R. RA Grate, Leslie Roy RA Mian, I. Saira RA Borowsky, Alexander David RA Jensen, Roy A. RA Idowu, Michael O. RA Chen, Fan-Qing RA Chen, David J. RA Petersen, Ole William RA Gray, Joe W. RA Bissell, Mina J. RT "A human breast cell model of preinvasive to invasive transition."; RL Cancer Res. 68:1378-1387(2008). //